| Product NDC: | 0069-0006 |
| Proprietary Name: | Etomidate |
| Non Proprietary Name: | Etomidate |
| Active Ingredient(s): | 2 mg/mL & nbsp; Etomidate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-0006 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078289 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120203 |
| Package NDC: | 0069-0006-01 |
| Package Description: | 10 VIAL in 1 CARTON (0069-0006-01) > 10 mL in 1 VIAL (0069-0006-02) |
| NDC Code | 0069-0006-01 |
| Proprietary Name | Etomidate |
| Package Description | 10 VIAL in 1 CARTON (0069-0006-01) > 10 mL in 1 VIAL (0069-0006-02) |
| Product NDC | 0069-0006 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Etomidate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120203 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
| Substance Name | ETOMIDATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |